S. 4152 · 117th Congress · Senate
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill Text Versions
1Introduced in Senate
Published: May 5, 2022
USLM Available